Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunoinformatics‐aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019‐nCoV
Vargab Baruah, Sujoy Bose
Journal of Medical Virology (2020) Vol. 92, Iss. 5, pp. 495-500
Open Access | Times Cited: 274

Showing 1-25 of 274 citing articles:

Coronavirus Disease 2019–COVID-19
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, et al.
Clinical Microbiology Reviews (2020) Vol. 33, Iss. 4
Open Access | Times Cited: 1786
Immunology of COVID-19: Current State of the Science
Nicolas Vabret, Graham J. Britton, Conor Gruber, et al.
Immunity (2020) Vol. 52, Iss. 6, pp. 910-941
Open Access | Times Cited: 1654
COVID-19 Vaccine: A comprehensive status report
Simran Kaur, Vandana Gupta
Virus Research (2020) Vol. 288, pp. 198114-198114
Open Access | Times Cited: 850
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics
Kuldeep Dhama, Khan Sharun, Ruchi Tiwari, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 6, pp. 1232-1238
Open Access | Times Cited: 636
COVID-19 vaccine development and a potential nanomaterial path forward
Matthew D. Shin, Sourabh Shukla, Young Hun Chung, et al.
Nature Nanotechnology (2020) Vol. 15, Iss. 8, pp. 646-655
Open Access | Times Cited: 623
Human Leukocyte Antigen Susceptibility Map for Severe Acute Respiratory Syndrome Coronavirus 2
Austin Nguyen, Julianne K. David, Sean K. Maden, et al.
Journal of Virology (2020) Vol. 94, Iss. 13
Open Access | Times Cited: 525
Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review
Esteban Ortíz-Prado, Katherine Simbaña‐Rivera, Lenin Gómez‐Barreno, et al.
Diagnostic Microbiology and Infectious Disease (2020) Vol. 98, Iss. 1, pp. 115094-115094
Open Access | Times Cited: 370
Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
Ali Golchin, Ehsan Seyedjafari, Abdolreza Ardeshirylajimi
Stem Cell Reviews and Reports (2020) Vol. 16, Iss. 3, pp. 427-433
Open Access | Times Cited: 322
SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors
Alina S. Shomuradova, Murad Vagida, Savely A. Sheetikov, et al.
Immunity (2020) Vol. 53, Iss. 6, pp. 1245-1257.e5
Open Access | Times Cited: 239
Immune-epidemiological parameters of the novel coronavirus – a perspective
Amene Saghazadeh, Nima Rezaei
Expert Review of Clinical Immunology (2020) Vol. 16, Iss. 5, pp. 465-470
Open Access | Times Cited: 223
Immune responses and pathogenesis of SARS‐CoV‐2 during an outbreak in Iran: Comparison with SARS and MERS
Mohsen Rokni, Vida Ghasemi, Zahra Tavakoli
Reviews in Medical Virology (2020) Vol. 30, Iss. 3
Open Access | Times Cited: 218
COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses
Agnes Bonifacius, Sabine Tischer‐Zimmermann, Anna Christina Dragon, et al.
Immunity (2021) Vol. 54, Iss. 2, pp. 340-354.e6
Open Access | Times Cited: 203
SARS–CoV-2–specific T cell responses and correlations with COVID-19 patient predisposition
Arne Sattler, Stefan Angermair, Helena Stockmann, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 12, pp. 6477-6489
Open Access | Times Cited: 202
The prevalence of compassion satisfaction and compassion fatigue among nurses: A systematic review and meta-analysis
Wanqing Xie, Lingmin Chen, Fen Feng, et al.
International Journal of Nursing Studies (2021) Vol. 120, pp. 103973-103973
Closed Access | Times Cited: 190
SARS-CoV-2 Proteome Microarray for Mapping COVID-19 Antibody Interactions at Amino Acid Resolution
Hongye Wang, Xian Wu, Xiaomei Zhang, et al.
ACS Central Science (2020) Vol. 6, Iss. 12, pp. 2238-2249
Open Access | Times Cited: 186
Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches
Rong Dong, Zhugang Chu, Fuxun Yu, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 174
Full-genome sequences of the first two SARS-CoV-2 viruses from India
SarahS Cherian, Pragya D. Yadav, VarshaA Potdar, et al.
The Indian Journal of Medical Research (2020) Vol. 151, Iss. 2, pp. 200-200
Open Access | Times Cited: 172
Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2
Peter Muench, Simon Jochum, Verena Wenderoth, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 10
Open Access | Times Cited: 168
Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
Kevin Ita
Archives of Medical Research (2020) Vol. 52, Iss. 1, pp. 15-24
Open Access | Times Cited: 160
Microstructure, pathophysiology, and potential therapeutics of COVID‐19: A comprehensive review
Satarudra Prakash Singh, Manisha Pritam, Brijesh Pandey, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 275-299
Open Access | Times Cited: 156
SARS-CoV-2: characteristics and current advances in research
Yicheng Yang, Zhiqiang Xiao, Kaiyan Ye, et al.
Virology Journal (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 151
The possible of immunotherapy for COVID-19: A systematic review
Akram AminJafari, Sorayya Ghasemi
International Immunopharmacology (2020) Vol. 83, pp. 106455-106455
Open Access | Times Cited: 132
The recent challenges of highly contagious COVID‐19, causing respiratory infections: Symptoms, diagnosis, transmission, possible vaccines, animal models, and immunotherapy
Ranjan K. Mohapatra, Lucia Pintilie, Venkataramana Kandi, et al.
Chemical Biology & Drug Design (2020) Vol. 96, Iss. 5, pp. 1187-1208
Open Access | Times Cited: 127
SARS-CoV-2 Vaccine Development: Current Status
Gregory A. Poland, Inna G. Ovsyannikova, Stephen N. Crooke, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 10, pp. 2172-2188
Open Access | Times Cited: 113
Fragment Molecular Orbital Based Interaction Analyses on COVID-19 Main Protease − Inhibitor N3 Complex (PDB ID: 6LU7)
Ryo Hatada, Koji Okuwaki, Yuji Mochizuki, et al.
Journal of Chemical Information and Modeling (2020) Vol. 60, Iss. 7, pp. 3593-3602
Open Access | Times Cited: 106
Page 1 - Next Page

Scroll to top